brentuximab vedotin
seagen,takeda
['lymsm']
quick poll for #asco22 #lymsm: based on just-reported echelon-1 os results, will you be switching to bv-avd for advanced-stage chl?
Hematology/oncology fellow. #lymsm & #mmsm outcomes researcher. Physician-publisher & founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. ??????